Valo Health Names Rita Kale CFO

Valo Health, Inc. (Valo), a company pioneering the use of human data and AI to accelerate drug discovery and development, appointed Rita Kale as Chief Financial Officer (CFO). Kale brings over two decades of global finance leadership in biopharma, diagnostics, and technology-enabled healthcare.

Kale previously served as CFO and Head of Corporate Management at Foundation Medicine, where she played a key role in driving product expansion and operational improvement. 

Earlier in her career, she held senior finance leadership roles at the Roche Group across Asia-Pacific and Sub-Saharan Africa; served as country CFO in South Africa and India; and led finance for Global Product Strategy in Switzerland. 

In these positions, Kale led strategic capital allocation and drove major business initiatives across complex healthcare markets, successfully securing funding for multiple product launches while accelerating organizational growth and scaling operations. 

Kale also serves on the board of CareMetx, a patient access services company.

“We are proud to welcome Rita Kale as Valo’s Chief Financial Officer during such a pivotal time at Valo,” said Brian Alexander, MD, MPH, CEO of Valo Health. “Rita’s deep financial expertise and proven track record of strategically scaling organizations make her an invaluable addition to our leadership team. Her ability to align financial strategy with scientific innovation will be instrumental as we accelerate our mission to transform drug discovery and deliver meaningful impact to patients in the future.”